A special offer from Managing IP

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

A special offer from Managing IP

MIP_logo_yellow_100

Do you enjoy reading our content? Would you like full access? Well today is your lucky day!



mip-may-2015big.jpg

For today and tomorrow (December 2nd and 3rd) we are running a promotional event with 2 special offers for our readers:

-      30% off a single subscription: Save £500/€650/$895 on a subscription to Managing IP

-      5 users for the price of 2 – open up access for you and your colleagues while taking advantage of this special rate

A subscription to Managing IP gives you:

- Full access to the Managing IP archive going back to 1999

- Daily updates on the latest IP news and analysis

- Exclusive in-depth interviews with in-house counsel and regulators

- Results of the latest IP survey and awards ranking the top firms in IP

- In-depth articles on key developments, written by thought leaders

- Regular email updates with all the latest news, articles and offers

This offer is only available on December 2nd and 3rd until 5pm GMT so email info@managingip.com or call +44 (0) 207 779 8626 and we will get you set up as a subscriber. 



more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Schwitulla is the head of litigation management at Nokia in Germany
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article